| Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells AD Sanlioglu, E Dirice, C Aydin, N Erin, S Koksoy, S Sanlioglu BMC cancer 5, 1-17, 2005 | 162 | 2005 |
| Clinical utility of insulin and insulin analogs AD Sanlioglu, HA Altunbas, MK Balci, TS Griffith, S Sanlioglu Islets 5 (2), 67-78, 2013 | 77 | 2013 |
| The assessment of PTEN tumor suppressor gene in combination with Gleason scoring and serum PSA to evaluate progression of prostate carcinoma IT Koksal, E Dirice, D Yasar, AD Sanlioglu, A Ciftcioglu, KH Gulkesen, ... Urologic Oncology: Seminars and Original Investigations 22 (4), 307-312, 2004 | 68 | 2004 |
| DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells AD Sanlioglu, B Karacay, IT Koksal, TS Griffith, S Sanlioglu Cancer gene therapy 14 (12), 976-984, 2007 | 66 | 2007 |
| TRAIL Death Receptor–4 Expression Positively Correlates With the Tumor Grade in Breast Cancer Patients With Invasive Ductal Carcinoma AD Sanlioglu, AF Korcum, E Pestereli, G Erdogan, S Karaveli, B Savas, ... International Journal of Radiation Oncology* Biology* Physics 69 (3), 716-723, 2007 | 65 | 2007 |
| Differential expression of TRAIL and its receptors in benign and malignant prostate tissues AD Sanlioglu, IT Koksal, A Ciftcioglu, M Baykara, G Luleci, S Sanlioglu The Journal of urology 177 (1), 359-364, 2007 | 59 | 2007 |
| Therapeutic potential of VIP vs PACAP in diabetes AD Sanlioglu, B Karacay, MK Balci, TS Griffith, S Sanlioglu Journal of molecular endocrinology 49 (3), R157-R167, 2012 | 57 | 2012 |
| High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients AD Sanlioglu, E Dirice, O Elpek, AF Korcum, M Ozdogan, I Suleymanlar, ... Pancreas 38 (2), 154-160, 2009 | 57 | 2009 |
| Adenovirus-mediated IKKβKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis AD Sanlioglu, IT Koksal, B Karacay, M Baykara, G Luleci, S Sanlioglu Cancer Gene Therapy 13 (1), 21-31, 2006 | 55 | 2006 |
| Adenovirus-mediated TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets prolongs normoglycemia in streptozotocin-induced diabetic rats E Dirice, AD Sanlioglu, S Kahraman, S Ozturk, MK Balci, A Omer, ... Human gene therapy 20 (10), 1177-1189, 2009 | 48 | 2009 |
| Decoy receptor-2 small interfering RNA (siRNA) strategy employing three different siRNA constructs in combination defeats adenovirus-transferred tumor necrosis factor-related … C Aydin, AD Sanlioglu, B Karacay, G Ozbilim, L Dertsiz, O Ozbudak, ... Human gene therapy 18 (1), 39-50, 2007 | 47 | 2007 |
| Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma AD Sanlioglu, C Aydin, H Bozcuk, E Terzioglu, S Sanlioglu Lung cancer 44 (2), 199-211, 2004 | 47 | 2004 |
| Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer U Mert, AD Sanlioglu Cellular and Molecular Life Sciences 74, 245-255, 2017 | 43 | 2017 |
| Network-aware virtual machine placement in cloud data centers with multiple traffic-intensive components AR Ilkhechi, I Korpeoglu, Ö Ulusoy Computer Networks 91, 508-527, 2015 | 43 | 2015 |
| High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas AD Sanlioglu, E Dirice, O Elpek, AF Korcum, MK Balci, A Omer, TS Griffith, ... Pancreas 36 (4), 385-393, 2008 | 43 | 2008 |
| Molecular analysis of beta-thalassemia and sickle cell anemia in Antalya I Keser, AD Sanlioglu, E Manguoglu, O Guzeloglu Kayisli, N Nal, F Sargin, ... Acta haematologica 111 (4), 205-210, 2004 | 42 | 2004 |
| Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased … IT Koksal, AD Sanlioglu, B Karacay, TS Griffith, S Sanlioglu Urologic Oncology: Seminars and Original Investigations 26 (2), 158-165, 2008 | 41 | 2008 |
| Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis E Terzioglu, A Bisgin, AD Sanlioglu, M Ulker, V Yazisiz, S Tuzuner, ... Rheumatology 46 (5), 783-789, 2007 | 41 | 2007 |
| Molecular mechanisms of death ligand‐mediated immune modulation: A gene therapy model to prolong islet survival in type 1 diabetes AD Sanlioglu, TS Griffith, A Omer, E Dirice, R Sari, HA Altunbas, MK Balci, ... Journal of Cellular Biochemistry 104 (3), 710-720, 2008 | 40 | 2008 |
| Association of circulating sTRAIL and high-sensitivity CRP with type 2 diabetic nephropathy and foot ulcers HO Arık, AD Yalcin, S Gumuslu, GE Genç, A Turan, AD Sanlioglu Medical science monitor: international medical journal of experimental and …, 2013 | 32 | 2013 |
